BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 19152212)

  • 21. Metabonomic modeling of drug toxicity.
    Keun HC
    Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Web-based resources for mass-spectrometry-based metabolomics: a user's guide.
    Tohge T; Fernie AR
    Phytochemistry; 2009 Mar; 70(4):450-6. PubMed ID: 19285697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
    Antonucci R; Atzori L; Barberini L; Fanos V
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolomics of carotenoids in engineered cell factory.
    Liu GN; Zhu YH; Jiang JG
    Appl Microbiol Biotechnol; 2009 Jul; 83(6):989-99. PubMed ID: 19529930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical and statistical approaches to metabolomics research.
    Issaq HJ; Van QN; Waybright TJ; Muschik GM; Veenstra TD
    J Sep Sci; 2009 Jul; 32(13):2183-99. PubMed ID: 19569098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics in monitoring kidney transplants.
    Wishart DS
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):637-42. PubMed ID: 17053480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic profiling as a tool for understanding mechanisms of toxicity.
    Clarke CJ; Haselden JN
    Toxicol Pathol; 2008 Jan; 36(1):140-7. PubMed ID: 18337232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics: towards understanding traditional Chinese medicine.
    Zhang A; Sun H; Wang Z; Sun W; Wang P; Wang X
    Planta Med; 2010 Dec; 76(17):2026-35. PubMed ID: 21058239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of proteomic and metabolomic profiling as well as metabolic modeling for the functional analysis of metabolic networks.
    May P; Christian N; Ebenhöh O; Weckwerth W; Walther D
    Methods Mol Biol; 2011; 694():341-63. PubMed ID: 21082444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics: a new tool for the neonatologist.
    Atzori L; Antonucci R; Barberini L; Griffin JL; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():50-3. PubMed ID: 19701858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomics of cancer.
    Serkova NJ; Glunde K
    Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial metabolomics: past, present and future methodologies.
    Mashego MR; Rumbold K; De Mey M; Vandamme E; Soetaert W; Heijnen JJ
    Biotechnol Lett; 2007 Jan; 29(1):1-16. PubMed ID: 17091378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MetaNetwork: a computational protocol for the genetic study of metabolic networks.
    Fu J; Swertz MA; Keurentjes JJ; Jansen RC
    Nat Protoc; 2007; 2(3):685-94. PubMed ID: 17406631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current progress in computational metabolomics.
    Wishart DS
    Brief Bioinform; 2007 Sep; 8(5):279-93. PubMed ID: 17626065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unveiling cellular biochemical reactions via metabolomics-driven approaches.
    Saito N; Ohashi Y; Soga T; Tomita M
    Curr Opin Microbiol; 2010 Jun; 13(3):358-62. PubMed ID: 20430690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR-based plant metabolomics: where do we stand, where do we go?
    Kim HK; Choi YH; Verpoorte R
    Trends Biotechnol; 2011 Jun; 29(6):267-75. PubMed ID: 21435731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.
    Leclercq L; Cuyckens F; Mannens GS; de Vries R; Timmerman P; Evans DC
    Chem Res Toxicol; 2009 Feb; 22(2):280-93. PubMed ID: 19183054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.